Evidence map›Paper›PMID 38678096›Full record

ArticleScientific reports2024

Gastrointestinal bleeding in elderly patients with atrial fibrillation: prespecified All Nippon Atrial Fibrillation in the Elderly (ANAFIE) Registry subgroup analysis.

Takatsugu Yamamoto, Yuji Mizokami, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Yukihiro Koretsune, Ken Okumura, Wataru Shimizu, Shinya Suzuki and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 14 institutions in 1 country.

Takatsugu YamamotoDepartment of Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan. ymmt@med.teikyo-u.ac.jp.
Yuji MizokamiDepartment of Gastroenterology, New Tokyo Hospital, Matsudo, Chiba, Japan.
Takeshi YamashitaThe Cardiovascular Institute, Minato-ku, Tokyo, Japan.
Masaharu AkaoDepartment of Cardiology, National Hospital Organization Kyoto Medical Center, Fushimi-ku, Kyoto, Japan.
Hirotsugu AtarashiAOI Hachioji Hospital, Hachioji, Tokyo, Japan.
Takanori IkedaDepartment of Cardiovascular Medicine, Toho University Faculty of Medicine, Ota-ku, Tokyo, Japan.
Yukihiro KoretsuneNational Hospital Organization Osaka National Hospital, Chuo Ward, Osaka, Japan.
Ken OkumuraDivision of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Minami-ku, Kumamoto, Japan.
Wataru ShimizuDepartment of Cardiovascular Medicine, Nippon Medical School, Tama Nagayama Hospital, Tama, Tokyo, Japan.
Shinya SuzukiThe Cardiovascular Institute, Minato-ku, Tokyo, Japan.
Hiroyuki TsutsuiDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
Kazunori ToyodaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Atsushi HirayamaDepartment of Medicine, Osaka Fukujyuji Hospital, Neyagawa, Osaka, Japan.
Masahiro YasakaDepartment of Cerebrovascular Medicine, Fukuoka Neurosurgical Hospital, Minami-ku, Fukuoka, Japan.
Takenori YamaguchiDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Satoshi TeramukaiDepartment of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.
Tetsuya KimuraPrimary Medical Science Department, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan.
Yoshiyuki MorishimaPrimary Medical Science Department, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan.
Atsushi TakitaData Intelligence Department, Daiichi Sankyo Co., Ltd., Shinagawa-ku, Tokyo, Japan.
Hiroshi InoueSaiseikai Toyama Hospital, Toyama, Toyama, Japan.
Daiichi-Sankyo (Japan) · JPCardiovascular Institute Hospital · JPNational Cerebral and Cardiovascular Center · JPKyoto Medical Center · JPKyoto Prefectural University of Medicine · JPKyushu University · JPNew Tokyo Hospital · JPNippon Medical School · JPOsaka National Hospital · JPSaiseikai Kumamoto Hospital · JPTeikyo University · JPToho University · JPToyama University Hospital · JPUji Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal (GI) bleeding control is critical in elderly patients with atrial fibrillation (AF) receiving oral anticoagulants (OAC). This subgroup analysis aimed to clarify the actual state and significance of GI bleeding in elderly non-valvular AF (NVAF) patients. We evaluated the incidence and risk factors of GI bleeding during the 2-year follow-up and examined the GI bleeding impact on mortality. Of the 32,275 patients in the ANAFIE Registry, 1139 patients (3.5%) experienced GI bleeding (incidence rate, 1.92 events per 100 person-years; mean follow-up, 1.88 years); 339 upper and 760 lower GI bleeding events occurred. GI bleeding risk factors included age ≥ 85 years, body mass index ≥ 25.0 kg/m

Indexed as

AnticoagulantsAtrial FibrillationGastrointestinal HemorrhageRegistriesAgedAged, 80 and overFemaleHumansIncidenceMaleRisk FactorsWarfarinAnticoagulantsWarfarin

Identifiers

PMID38678096
PMCPMC11055876
OpenAlexW4395692256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.